Lundbeck reports positive phase 2b results for migraine prevention drug
16th February 2026 Uncategorised 0
Bocunebart shows significant reduction in monthly migraine days in patients with previous treatment failures

More: Lundbeck reports positive phase 2b results for migraine prevention drug
Source: News
